UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000049149 |
|---|---|
| Receipt number | R000055987 |
| Scientific Title | Survey of anti-CGRP monoclonal antibodies in Japan |
| Date of disclosure of the study information | 2022/10/07 |
| Last modified on | 2023/01/23 07:08:56 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Survey of anti-CGRP monoclonal antibodies in Japan
Acronym
Survey of anti-CGRP monoclonal antibodies in Japan
Scientific Title
Survey of anti-CGRP monoclonal antibodies in Japan
Scientific Title:Acronym
Survey of anti-CGRP monoclonal antibodies in Japan
Region
| Japan |
Condition
Condition
Migraine
Classification by specialty
| Medicine in general | Neurology | Neurosurgery |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To clarify how Japanese doctors decide to prescribe CGRPmAbs etc.
Basic objectives2
Others
Basic objectives -Others
To clarify number of migraineurs doctors are seeing, and their time with each patient etc.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Criteria for prescribing CGRPmAbs
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Members of The Japanese Headache Society (Medical Doctors)
Key exclusion criteria
Non-medical doctors
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Tsubasa |
| Middle name | |
| Last name | Takizawa |
Organization
Keio University School of Medicine
Division name
Department of Neurology
Zip code
160-8582
Address
35 Shinanomachi, Shijuku-ku, Tokyo
TEL
0353633788
tsubasa.takizawa@z5.keio.jp
Public contact
Name of contact person
| 1st name | Tsubasa |
| Middle name | |
| Last name | Takizawa |
Organization
Keio University School of Medicine
Division name
Department of Neurology
Zip code
160-8582
Address
35 Shinanomachi, Shijuku-ku, Tokyo
TEL
0353633788
Homepage URL
tsubasa.takizawa@z5.keio.jp
Sponsor or person
Institute
Department of Neurology, Keio University School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Ministry of Education, Culture, Sports, Science and Technology
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Task force for the use of anti-CGRP monoclonal antibodies, The Japanese Headache Society
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Keio University School of Medicine
Address
35 Shinanomachi, Shijuku-ku, Tokyo
Tel
0353633788
med-rinri-jimu@adst.keio.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2022 | Year | 10 | Month | 07 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2022 | Year | 09 | Month | 27 | Day |
Date of IRB
| 2022 | Year | 09 | Month | 27 | Day |
Anticipated trial start date
| 2022 | Year | 12 | Month | 22 | Day |
Last follow-up date
| 2033 | Year | 01 | Month | 22 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
n/a
Management information
Registered date
| 2022 | Year | 10 | Month | 07 | Day |
Last modified on
| 2023 | Year | 01 | Month | 23 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055987
